BioSpace News Archive

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share.

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Kathleen M. Snyder has joined the firm’s technology and commercial transactions practice as Of Counsel in the Boston office

In a new article published in the December issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the authors offer an in-depth analysis of the latest 3D printing technology and explore its impact on patient care.

Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53

PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that its GSP® Neonatal Creatine Kinase –MM (CK-MM) kit has received U.S. Food & Drug Administration (FDA) approval.

Omeros Corporation (Nasdaq: OMER) (“Omeros”), announced today the full exercise and closing of the sale of 572,518 shares of common stock to the underwriter of its previously announced public offering pursuant to the underwriter’s option under the underwriting agreement to purchase additional shares of common stock.

PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Human Care Systems as one of the most innovative companies of 2019.

Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announces the approval from the United States Patent and Trademark Office (USPTO) for a patent covering the clinical use of a biomarker analysis to detect cancer patients ability to respond to folate-based therapy cancer treatments.

Puration, Inc. (USOTC: PURA) today confirmed a scheduled update with more details on the company’s recently announced 2020 expansion plan to be released next week on Tuesday, December 17, 2019. PURA’s expansion is intended to substantially increase PURA’s 2020 prospects beyond its current $8 million revenue target.

Arthroscopy, also known as arthroscopic or keyhole surgery, is a minimally invasive surgical procedure on a joint. An arthroscope, a device with a camera is inserted into the joint through a small incision in arthroscopy.